Implementation of a pharmacist-initiated pharmaceutical handover for oncology and haematology patients being transferred to critical care units

Supportive Care in Cancer

Volumn 18, Issue 7, 2010, Pages 811-816

  Coutsouvelis, John ^a   Corallo, Carmela E ^a   Dooley, Michael J ^a,b   Foo, Josephine ^c   Whitfield, Ann ^c  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c BOX HILL HOSPITAL   (Australia)

Author keywords

Clinical pharmacy; Critical care; Handover; Intervention; Oncology

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; GROWTH FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; COLORECTAL CANCER; ESOPHAGUS CANCER; FEMALE; HEMATOLOGY; HODGKIN DISEASE; HUMAN; INTENSIVE CARE UNIT; LEUKEMIA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; NONHODGKIN LYMPHOMA; ONCOLOGY; PANCREAS CANCER; PHARMACIST; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CONTINUITY OF PATIENT CARE; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOLOGY; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE UNITS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASMS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT TRANSFER; PHARMACY SERVICE, HOSPITAL; PROGRAM EVALUATION;

EID: 77953619380     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0713-4     Document Type: Article

References (30)

1. Bond CA, Raehl CL (2008) 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors and pharmacy technology. Phramacotherapy 28:1-13
2. Bond CA, Raehl CL (2007) Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy 27:481-493
3. Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J et al (2004) A prospective multicentre study on pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol 57:512-521
4. Kaboli PJ, Hoth AB, McClinnon BJ, Schipper JL (2006) Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 1666:955-964
5. Royal S, Smeaton L, Avery AJ, Humitz B, Sheikh A (2006) Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care 15:23-31
6. Schiffer CA (2003) Differences in outcome in adolescents with acute lymphoblastic leukaemia: a consequence of better regimens? Better doctors? Both? J Clin Oncol 21:760-761
7. Skeel RT (2003) Handbook of cancer chemotherapy, 6th edn. Lippincott Williams & Wilkins, Philadelphia
8. Caggiano V, Weiss RV, Rickert TS, Linde-Zwirble WT (2005) Incidence, cost, and mortality of neutropenia hospitilization associated with chemotherapy. Cancer 103:1916-1924
9. Dekker A, Bulley S, Beyene J, Dupuis LL, Doyle JJ, Sung L (2006) Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogenic stem cell transplantation. J Clin Oncol 24:5207-5215
10. Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L et al (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practical guideline. J Clin Oncol 24:3187-3205
11. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589-1596
12. Bergmann OJ, Mogensen SC, Ellermarm-Eriksen S, Ellegaard J (1997) Acyclovir prophylaxis and fever during remission- induction therapy of patients with acute myeloid leukemia: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 15:2269-2274
13. Cullen MH, Billingham LJ, Gaunt CH, Steven NM (2007) Rational selection of patients for antibacterial prophylaxis after chemotherapy. J Clin Oncol 25:4821-4828
14. eTG complete; Antibiotic (2008) Therapeutic Guidelines Limited, Melbourne. http://etg.tg.com.au.ezproxy.lib.monash.edu.au. Accessed 14 Sept 2008
15. Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurum M, Leibovici L et al (2007) Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol 25:5471-5489
16. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33-39
17. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Eldelsberg J et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201-2205
18. SHPA practice standards and definitions (2007) The Society of Hospital Pharmacists of Australia, Collingwood. http://www.shpa.org.au. Accessed 6 October 2008
19. The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Critical Care (2002) SHPA standards of practice for critical care pharmacy practice. J Pharm Pract Res 32:115-118
20. The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Oncology (2008) SHPA standards of practice for the provision of clinical oncology pharmacy services. J Pharm Pract Res 38:58-60
21. Bonaventura A (1995) Complications of cytotoxic therapy - Part 2. Aust Prescr 18:105-107
22. Mughal TI, Goldman JM, Mughal ST (2006) Understanding leukemias, lymphomas and myelomas, 1st edn. Taylor and Francis, UK
23. Shanholtz C (2001) Acute life-threatening toxicity of cancer treatment. Crit Care Clin 17:483-502
24. Bourget S, Allenet B, Bedouch P, Bosson JL, Calpo J (2007) Physicians' expectations towards pharmacy services on the ward. J Pharm Belg 62:130-134
25. Liekweg A, Westfeld M, Jaehde U (2004) From oncology pharmacy to pharmaceutical care: new contributions to multidis- ciplinary cancer care. Support Care Cancer 12:73-79
26. Price SO, Newnham MA (1994) Physician perceptions of clinical pharmacy encounters in a family practice clinic. Top Hosp Pharm Manage 14:13-20
27. Schwartzberg E, Rubinovich S, Hassin D, Haspel J, Ben-Moshe A, Oren M et al (2006) Developing and implementing a model for changing physicians' prescribing habits - the role of clinical pharmacy in leading the change. J Clin Pharm Ther 31:179-185
28. Shirley CV, Mutnick AH, Daniel WL, Volles D (2006) Evaluation of a pharmacy clinical practice model by other healthcare professionals. Proceedings from ASHP Midyear Clinical Meeting, vol 41. American Society of Health-System Pharmacists, Bathesda
29. Department of Human Services, Victoria (2007) National inpatient medication chart. Victorian evaluation, Melbourne. www.health.vic.gov.au/vmac. Accessed 10 Oct 2008
30. Millar JA, Silla RC, Lee GE, Berwick A (2008) The national inpatient medication chart: critical audit of design and performance at a tertiary hospital. Med J Aust 188:95-99